FIELD: gene engineering.
SUBSTANCE: invention concerns gene engineering, particularly immunogenic conjugates, and can be applied in treatment and prevention of states related to angiotensin system activated by renin. Virus-like part of RNA bacteriophage is conjugated with angiotensin peptide component by non-peptide covalent link. Obtained conjugate of angiotensin peptide component with carrier is applied in immunisation.
EFFECT: conjugate of angiotensin peptide component with carrier.
29 cl, 8 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONJUGATES OF GHRELIN CARRIER | 2003 |
|
RU2325202C2 |
| ANTIGEN MATRIX FOR TREATMENT OF BONE DISEASE | 2002 |
|
RU2322258C2 |
| COMPOSITION FOR IMMUNIZATION (VARIANTS), METHOD FOR ITS PREPARING AND USING FOR TREATMENT OF ALLERGIC EOSINOPHILIC DISEASES | 2002 |
|
RU2319503C2 |
| CONJUGATES OF PEPTIDE Melan-A, VIRUS-LIKE PARTICLE ANALOGUE | 2004 |
|
RU2351362C2 |
| ANTIGEN MOLECULAR MASSIFS | 2003 |
|
RU2324704C2 |
| HAPTEN-CARRIER CONJUGATES AND APPLICATION | 2003 |
|
RU2326693C2 |
| COMPOSITION AND IMMUNIZATION METHOD, METHODS FOR PRODUCING NON-NATURAL, ORDERED AND REPEATED ANTIGEN MASSIVE AND COAT PROTEIN | 2002 |
|
RU2295973C2 |
| COMPOSITION AND METHOD FOR IMMUNIZATION, METHOD FOR PRODUCING OF NON-NATURAL, ORDERED AND REPEATED ANTIGEN MASSIVE | 2002 |
|
RU2294211C2 |
| CAT ALLERGEN FUSED PROTEIN AND APPLICATION THEREOF | 2006 |
|
RU2414239C2 |
| INTERLEUKIN-1 CONJUGATES AND THEIR APPLICATION | 2006 |
|
RU2441067C2 |
